Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. DELL
3. ROIV
4. ANET
5. NKE
6. PANW
7. CL
8. SNDK
9. TAP
10. EAT

Go back to Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan
(NASDAQ: ACRS) Delayed: 6.17 +0.22 (3.70%)
Previous Close $5.95    52 Week High $33.88 
Open $5.97    52 Week Low $14.12 
Day High $6.20    P/E N/A 
Day Low $5.87    EPS $0.00 
Volume 1,746,646